==== Front
Int J NanomedicineInt J NanomedicineInternational Journal of NanomedicineInternational Journal of Nanomedicine1176-91141178-2013Dove Medical Press 10.2147/IJN.S178282ijn-13-4507ErratumEngineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [Erratum] 2018 07 8 2018 07 8 2018 13 4507 4507 © 2018 Liang et al. This work is published and licensed by Dove Medical Press Limited2018Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
==== Body
Liang G, Kan S, Zhu Y, et al. Int J Nanomedicine. 2018;13:585–599.

On page 586, the 1st heading, right hand column should read “Materials and methods” instead of “Patients and methods”.